98%
921
2 minutes
20
Many studies have been conducted to quantify microplastic contamination, but only a few of them have actually the sampling methodology and associated uncertainties. This study seeks to examine the influence of sampling strategy on the confidence interval of river microplastic estimates. 16 samples are collected in the Gave de Pau River (southwestern France) during a three-hour window with a 330-μm mesh size net. Three different exposure times (3, 5 and 7 min) allow for a respective filtration rate by the net of 35.6 m (3 samples), 59.4 m (10 samples), and 83.2 m (3 samples) of water. Organic matter contained in samples is removed by hydrogen peroxide oxidation. The plastic particles are then counted and classified under a binocular microscope. The microplastic concentrations vary between 2.64 and 4.24 microplastics/m, with a median value of 3.26 microplastics/m. Statistical analysis does not show differences in microplastic concentrations for the three exposure times. This result seems to demonstrate that a filtration of approx. 35 m of water is sufficient under similar conditions (similar flow condition and degree of microplastic contamination) and can help reduce sampling and sample processing time. Other analyses, based on 10 filtrations of 59.4 m, show that the higher the number of samples, the lower the confidence interval. For triplicates, the mean confidence interval reaches 15% of the median value. Thus, collecting triplicates would seem to offer a reasonable optimum, in combining an acceptable error percentage and time efficiency. These results might depend on the microplastic load of the river, therefore making it necessary to conduct similar analyses on other rivers. This study reports for the first time uncertainties related to microplastic sampling in rivers. Such findings will serve to set up long term monitoring, highlight spatial differences between sites and improve the accuracy of annual microplastic fluxes in rivers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scitotenv.2020.137319 | DOI Listing |
Pharmacotherapy
September 2025
Department of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Background: Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy. However, the contribution of genetic polymorphisms in CYP enzymes remains unclear.
View Article and Find Full Text PDFMed J Aust
September 2025
Sydney School of Public Health, the University of Sydney, Sydney, NSW.
Objectives: To assess changes in greenhouse gas emission rates associated with the use of anaesthetic gases (desflurane, sevoflurane, and isoflurane) in Australian health care during 2002-2022, overall and by state or territory and hospital type.
Study Design: Retrospective descriptive analysis of IQVIA anaesthetic gases purchasing data.
Setting: All Australian public and private hospitals, 1 January 2002 - 31 December 2022.
Obstet Gynecol Sci
September 2025
Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea.
Objective: This study aimed to compare the outcomes of excision (conization) and active surveillance in women under 35 years of age diagnosed with cervical intraepithelial neoplasia 2 (CIN 2) on disease regression to normal cervical cytology and the effectiveness of nonsurgical management.
Methods: This retrospective cohort study was conducted at OOO. Women under 35 diagnosed with CIN 2 were included and divided into two groups based on the management strategy: excisional treatment or active surveillance.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Hepatobiliary and Pancreatic Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Objectives: In recent years, the role of remnant cholesterol (RC) in the development and progression of cardiovascular diseases has gained increasing attention. However, evidence on the association between RC and subclinical atherosclerosis is limited. This study aims to examine the relationship between RC and atherosclerotic plaques in single and multiple vascular territories.
View Article and Find Full Text PDFClin Transplant Res
September 2025
Division of Nephrology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea.
Background: Calcineurin inhibitor (CNI) toxicity is a significant cause of graft dysfunction in kidney transplant recipients, yet distinguishing it from acute rejection (AR) and acute tubular necrosis (ATN) remains challenging. This study investigated the use of urinary mRNA biomarkers as a noninvasive tool for identifying CNI toxicity.
Methods: We retrospectively enrolled 110 kidney transplant recipients and classified them into four groups based on pathological findings: stable graft function (n=35), CNI toxicity (n=25), AR (n=30), and ATN (n=20).